In Brief This Week: Life Technologies, FTC; Abbott; Saladax; PerkinElmer; Vermillion; More | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies said late last week in a regulatory filing that it has received a second request from the US Federal Trade Commission for more information about its pending $13.6 billion sale to Thermo Fisher Scientific. The company said it is cooperating with FTC and continues to expect the acquisition to close in early 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.